XD Market

Exosome Diagnostics, a Bio-Techne brand, is a pioneer in the development and commercialization of non-invasive liquid biopsy tests. The company utilizes its proprietary platform to isolate and analyze exosomes from various biofluids, such as urine and blood, to provide high-sensitivity molecular diagnostics. Their flagship product, the ExoDx Prostate test, helps clinicians determine the risk of high-grade prostate cancer without the need for an initial biopsy. By leveraging exosomal RNA and DNA, the company provides insights into disease progression and treatment response across oncology and other therapeutic areas. The company's commercial portal, known as XD Market, serves as the primary marketplace for clinicians and patients to access their diagnostic services.